Abbott Labs reported Q2 2026 adjusted EPS of $1.31, beating estimates, and raised its full-year adjusted EPS forecast to $5.45-$5.60 from $5.38-$5.58.
LiveSquawk07/16, 06:33 PM
- $1.31 (est $1.276)
- $5.45 To $5.60, Saw $5.38 To $5.58
- +4.8%
- $12.59B (est $12.54B)
Figures as quoted by LiveSquawk
Related assets
Coming up for ABT
Explore next
Latest ABT news
Bloomberg08/21, 04:57 PM
FirstSquawk08/21, 06:28 AM
FirstSquawk08/21, 06:28 AM